NSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Insperity Inc (NSP) is not a strong buy for a beginner investor with a long-term focus at this moment. The technical indicators suggest a bearish trend, and while there is some hedge fund buying, the financial performance and analyst sentiment indicate uncertainty. Given the lack of strong positive catalysts and the current market conditions, holding off on buying is the most prudent action.
The technical indicators show a bearish trend. The MACD is negative and contracting (-0.806), RSI is neutral at 27.694, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 21.452), but there is no clear upward momentum.
Hedge funds are significantly increasing their buying activity, with a 247.65% increase in the last quarter. The company has declared a quarterly dividend of $0.60 per share, which may appeal to income-focused investors.
Analyst sentiment is mixed to negative, with several firms lowering price targets and expressing concerns about healthcare costs and a stagnant small business hiring environment. The financials show a net loss (-$33M) and declining gross margin (-25.25% YoY). Technical indicators are bearish, and there is no recent congress trading data to support confidence.
In Q4 2025, revenue increased by 3.41% YoY to $1.668 billion. However, the company reported a net loss of $33 million, up 266.67% YoY, and EPS improved to -$0.87. Gross margin dropped significantly to 9.59%, down 25.25% YoY, indicating cost pressures.
Analysts have mixed views. Roth Capital maintains a Buy rating but lowered the price target to $56 from $61, citing uncertainty in healthcare costs and hiring trends. JPMorgan and Baird analysts maintain Neutral or Underweight ratings, with price targets around $35-$36. The sentiment reflects cautious optimism but highlights significant risks.
